P833: CATEGORIZING HEMATOLOGICAL RESPONSE TO PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS OF THE PHASE 3 PRINCE STUDY DATA
A. Risitano,
R. Wong,
M. Al-Adhami,
J. Savage,
R. Horneff,
R. Peffault de Latour
Affiliations
A. Risitano
1 Hematology and BMT Unit, AORN, San Giuseppe Moscati, Avellino, Italy
R. Wong
2 Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
M. Al-Adhami
3 Apellis Pharmaceuticals, Inc., Waltham, United States of America
J. Savage
3 Apellis Pharmaceuticals, Inc., Waltham, United States of America
R. Horneff
4 Swedish Orphan Biovitrum AB, Stockholm, Sweden
R. Peffault de Latour
5 French Reference Center for Aplastic Anemia and Paroxysmal Noctural Hemoglobinuria, Assistance Publique - Hôpitaux de Paris; Université de Paris, Paris, France